1779 — LongBio Pharma (Suzhou) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.53bn
- HK$3.52bn
Annual cashflow statement for LongBio Pharma (Suzhou), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -137 | -176 |
| Depreciation | ||
| Non-Cash Items | 31.1 | 25.3 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -5.12 | 21.6 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -104 | -121 |
| Capital Expenditures | -6.14 | -4.39 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -39.4 | -52.8 |
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -45.6 | -57.1 |
| Financing Cash Flow Items | 58.5 | 236 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 99.1 | 209 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -50.6 | 28.4 |